Document is current
Any future updates will be listed below
-
Authors
Galeano, Sebastian https://orcid.org/0000-0002-8048-2892
Bonfim, Carmem https://orcid.org/0000-0003-0343-2610
Karduss, Amado https://orcid.org/0000-0001-8372-102X
Jaimovich, Gregorio https://orcid.org/0000-0003-2555-6673
Gómez-De León, Andrés https://orcid.org/0000-0001-6904-9345
Bettarello, Gustavo
Simione, Anderson
Correa, Cinthya
Baldomero, Helen https://orcid.org/0000-0002-6554-483X
Neumann, Daniel https://orcid.org/0000-0002-4639-5189
Basquiera, Ana Lisa https://orcid.org/0000-0001-9892-5543
Berro, Mariano https://orcid.org/0000-0002-0552-444X
Remaggi, Guillermina
Amaru, Ariel
Barroso, Fernando
Seber, Adriana
Barriga, Francisco
Palma, Julia
Puga, Bárbara https://orcid.org/0000-0002-3942-6987
Sánchez, Matías
Herrera, Juan Manuel
Hernández, Calixto
Gómez-Almaguer, David https://orcid.org/0000-0002-0460-6427
Gaytán Morales, Félix
Ruiz-Argüelles, Guillermo J. https://orcid.org/0000-0002-9335-0653
Mendoza, Ninotzka
Benítez, María Liz
Wong, Alfredo https://orcid.org/0000-0001-8257-4320
Pagés, Carolina
Hernández, Marcos https://orcid.org/0000-0002-3347-7230
Niederwieser, Dietger https://orcid.org/0000-0002-4737-1103
Rondelli, Damiano
Frutos, Cristóbal https://orcid.org/0000-0001-9994-3137
- License Information
-
More Information
Article History
Received: 12 September 2024
Revised: 23 March 2025
Accepted: 8 April 2025
First Online: 18 April 2025
Competing interests
: Andrés Gómez-De León: Honoraria: Janssen, Sanofi, Abbvie, Astellas, Amgen, BMS, Novartis. Advisory board: Pfizer, Janssen.
